How to Get Zetia (Ezetimibe) in Utah: Telehealth, Prescriptions, and Pharmacies

At a glance
- Drug / ezetimibe (brand: Zetia), oral tablet, 10 mg once daily
- Telehealth prescribing / legal in Utah for established and new patients
- Labs needed / fasting lipid panel, liver function tests (ALT/AST)
- Time to first dose / 2 to 5 days for telehealth plus mail-order
- Generic cost / approximately $10 to $30/month with discount cards
- Utah Medicaid / not routinely covered for hyperlipidemia adjunct use
- Who can prescribe / MD, DO, NP, PA (all licensed in Utah)
- LDL reduction / 13 to 20% as monotherapy; up to 25% added to a statin
- IMPROVE-IT trial / ezetimibe plus simvastatin cut major CV events by 6.4% vs statin alone
- 503A compounding / permitted by Utah-licensed 503A pharmacies
What Is Ezetimibe and Why Do Utah Patients Need It
Ezetimibe is a cholesterol-absorption inhibitor that blocks the Niemann-Pick C1-like 1 (NPC1L1) transporter in the small intestine, reducing dietary and biliary cholesterol uptake by roughly 50% [1]. Taken as a single 10 mg tablet once daily, it lowers LDL cholesterol by 13 to 20% on its own and adds a further 20 to 25% reduction when combined with a statin [2]. The FDA approved ezetimibe (Zetia) in 2002 for primary hyperlipidemia and familial hypercholesterolemia, and generic versions became widely available after 2017 [3].
Utah has above-average rates of cardiovascular disease risk factors. The CDC reports that approximately 11.4% of Utah adults have been told by a physician they have high blood cholesterol requiring medication, and heart disease remains the leading cause of death in the state [4]. For patients who cannot tolerate high-intensity statins, or who have not reached their LDL target on statin therapy alone, ezetimibe is a logical next step supported by ACC/AHA guidelines [5].
The landmark IMPROVE-IT trial (N=18,144) published in the New England Journal of Medicine in 2015 demonstrated that adding ezetimibe 10 mg to simvastatin 40 mg reduced the composite of cardiovascular death, nonfatal MI, unstable angina, coronary revascularization, and nonfatal stroke by a statistically significant 6.4% relative risk reduction over seven years compared to simvastatin alone (P<0.001) [6]. Mean LDL at 1 year was 53.7 mg/dL in the combination group versus 69.5 mg/dL in the simvastatin-only group [6]. That trial provided the first randomized evidence that lowering LDL below the then-standard 70 mg/dL target with a non-statin agent translates into clinical benefit.
Utah Telehealth Rules for Zetia Prescriptions
Utah law permits telehealth prescribing of ezetimibe for both new and established patients, and no in-person visit is required to establish care. Utah Code Ann. Section 26-60-101 governs telehealth practice and requires that the provider conduct a real-time, two-way audio/video or audio-only interaction sufficient to meet the same standard of care as an in-person encounter [7]. A text-only asynchronous consultation alone does not satisfy this requirement for a new controlled or specialty prescription, though ezetimibe is not a controlled substance.
Utah's telehealth parity law, enacted in 2019, requires commercial insurers to cover telehealth visits at the same rate as in-person visits for the same service [7]. That means a telehealth lipid consultation billed under a covered evaluation-and-management code should cost the patient the same out-of-pocket as a brick-and-mortar office visit under most commercial plans.
Providers operating through telehealth platforms who prescribe to Utah patients must hold an active Utah medical license or a qualifying compact license. Utah is a member of the Interstate Medical Licensure Compact (IMLC), the Nurse Licensure Compact (NLC), and the PA Licensure Compact, so physicians, nurse practitioners, and physician assistants licensed in another compact state may often prescribe to Utah patients without a separate Utah license [7]. Patients should confirm the prescriber's license status on the Utah Division of Occupational and Professional Licensing (DOPL) website before the visit.
Telehealth platforms that commonly prescribe cardiovascular medications including ezetimibe to Utah patients include HealthRX, Teladoc Health, Hims & Hers, and direct-to-patient cardiology services. The standard workflow is: complete a health intake form, upload recent labs or schedule a lab draw, attend a video visit, and receive an e-prescription sent directly to your chosen pharmacy.
What Labs Are Required Before Starting Ezetimibe in Utah
A fasting lipid panel is the minimum required lab before any provider can responsibly prescribe ezetimibe. Most Utah telehealth providers also require baseline liver function tests (ALT and AST), because rare cases of hepatotoxicity have been reported with ezetimibe, and baseline values are needed for ongoing monitoring [1]. The ACC/AHA 2019 Guideline on the Primary Prevention of Cardiovascular Disease recommends a fasting lipid panel, a 10-year ASCVD risk calculation, and discussion of risk-enhancing factors before initiating any lipid-lowering therapy [5].
Specifically, you will generally need:
- Fasting lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides)
- ALT and AST (liver enzymes)
- Fasting glucose or HbA1c if diabetes risk is elevated
- TSH if hypothyroidism has not been ruled out, since untreated hypothyroidism causes secondary hypercholesterolemia [8]
Labs can be drawn at any LabCorp, ARUP (headquartered in Salt Lake City), Quest Diagnostics, or a Utah hospital outpatient lab. ARUP Laboratories processes most hospital-based lab work in Utah and accepts physician orders from telehealth providers [9]. Results typically return within 24 to 48 hours. If you have had a lipid panel within the past 12 months and no major dietary or medication changes have occurred, many providers will accept those prior results.
After starting ezetimibe, a repeat lipid panel at 4 to 12 weeks confirms the LDL response. A meta-analysis of 27 randomized trials (N=22,163) published in the European Heart Journal found that ezetimibe reduces LDL-C by a mean of 18.6 mg/dL (95% CI: 17.0 to 20.2 mg/dL) when added to background statin therapy [10]. Liver enzymes should be rechecked if the patient develops symptoms such as right-upper-quadrant discomfort, fatigue, or jaundice [1].
Who Can Prescribe Zetia in Utah
Utah-licensed MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs) can all prescribe ezetimibe. Ezetimibe is not a controlled substance, so there is no DEA Schedule restriction limiting who may write the prescription. Under Utah Code Ann. Section 58-31b-102, advanced practice registered nurses (APRNs) with a Utah prescriptive authority license can prescribe independently within their scope of practice, which includes lipid management [7]. PAs in Utah practice under a supervision agreement but may prescribe non-controlled medications including ezetimibe [7].
Pharmacists in Utah cannot prescribe ezetimibe independently, though collaborative drug therapy management (CDTM) agreements in some Utah health systems permit pharmacists to adjust doses of existing lipid prescriptions under a physician protocol.
The prescribing hierarchy in practice looks like this: a telehealth NP or PA screens your intake form and labs, escalates complex cases (familial hypercholesterolemia, concurrent liver disease, suspected secondary dyslipidemia) to a supervising physician, and issues the prescription electronically. For straightforward primary hyperlipidemia in an otherwise healthy adult, an NP or PA encounter is entirely appropriate and fully legal in Utah.
The HealthRX clinical team uses a three-tier triage framework for Utah ezetimibe requests. Tier 1 patients (LDL 100 to 189 mg/dL, no ASCVD, 10-year risk <7.5%) receive lifestyle counseling first and ezetimibe only if LDL remains above goal after 90 days. Tier 2 patients (LDL 100 to 189 mg/dL with statin intolerance or statin-inadequate response, or 10-year ASCVD risk 7.5 to 19.9%) receive same-visit ezetimibe prescribing after lab review. Tier 3 patients (established ASCVD, LDL above 70 mg/dL despite maximally tolerated statin, or familial hypercholesterolemia) receive ezetimibe plus a referral discussion for PCSK9 inhibitor therapy per the 2022 ACC Expert Consensus [11].
How to Transfer an Existing Zetia Prescription to Utah
If you are moving to Utah or establishing care with a new provider, transferring a Zetia prescription is straightforward. Federal law and Utah pharmacy regulations permit a pharmacist to transfer a non-controlled prescription between pharmacies one time (Utah Administrative Code R156-17b). For ongoing refills, the original prescriber must authorize the transfer or a new Utah-licensed provider must issue a new prescription.
Practically, the fastest path is to ask your out-of-state prescriber to send a new electronic prescription directly to a Utah pharmacy of your choice, or to a mail-order pharmacy that ships to Utah. If your prescriber is no longer available, a telehealth visit with a Utah-licensed provider, lasting about 15 to 20 minutes, is sufficient to establish care and issue a new prescription [7]. Bring a photo or PDF of your last prescription bottle and your most recent lipid panel results to expedite the visit.
Chain pharmacies including CVS, Walgreens, and Walmart allow prescription transfers between their own locations across state lines using their internal systems, so a Utah-store pharmacist can pull an existing Zetia prescription from any same-chain location in another state with one phone call.
Prior Authorization for Zetia in Utah: What to Expect
Prior authorization (PA) requirements for brand-name Zetia have largely disappeared now that generics are cheap, but some Utah commercial plans and Medicare Part D formularies still require step therapy before approving brand Zetia. Step therapy typically requires documentation that the patient tried a statin first, or that statins are contraindicated or not tolerated.
For generic ezetimibe 10 mg, most Utah commercial formularies place it on Tier 1 or Tier 2, meaning PA is rarely needed. Select Health (Intermountain Health's insurance arm), PEHP (the state employee plan), and Blue Cross Blue Shield of Utah all list generic ezetimibe on their preferred drug lists as of 2024.
Utah Medicaid (now called Utah Medicaid Managed Care) does not routinely cover ezetimibe for primary hyperlipidemia adjunct use. Patients on Medicaid may qualify for coverage under exceptions for familial hypercholesterolemia or documented ASCVD with statin failure if the prescriber submits a PA request with documentation of: (a) diagnosis code, (b) prior statin trial with dates and doses, (c) LDL values before and after statin therapy, and (d) a letter of medical necessity [12].
The ACC/AHA 2018 Cholesterol Guideline states: "In patients with clinical ASCVD in whom LDL-C remains above 70 mg/dL despite maximally tolerated statin therapy, it is reasonable to add ezetimibe to statin therapy" (Class IIa, Level of Evidence A) [5]. Quoting this guideline recommendation verbatim in a PA letter strengthens the medical necessity argument considerably.
For Medicare Part D, the Low Income Subsidy (LIS/Extra Help) program covers generic ezetimibe at minimal or no cost-sharing. Non-LIS Medicare patients typically pay $0 to $15 per month for generic ezetimibe on most Part D plans when purchased at a preferred pharmacy.
Utah Pharmacies That Dispense Ezetimibe
Every licensed retail pharmacy in Utah can dispense generic ezetimibe 10 mg tablets. The state has approximately 600 licensed retail pharmacies, including chains (CVS, Walgreens, Walmart, Smith's, Harmons) and independent pharmacies concentrated in Salt Lake City, Provo, Ogden, and St. George [13]. Mail-order options include Express Scripts, OptumRx, and Amazon Pharmacy, all of which ship to Utah addresses.
Generic ezetimibe pricing in Utah without insurance runs approximately $18 to $45 for a 30-day supply at retail. GoodRx coupons bring the cost down to $10 to $18 at most Utah Walmart and Costco pharmacy locations as of mid-2025. The Merck patient assistance program covers brand-name Zetia for patients meeting income criteria; the application is available at the Merck Helps website [3].
503A compounding pharmacies in Utah are licensed by the Utah Division of Occupational and Professional Licensing and may compound ezetimibe preparations (for example, oral suspensions for patients with swallowing difficulties) when a prescriber documents a valid clinical need that cannot be met by the commercially available tablet [13]. 503A compounders cannot produce ezetimibe in anticipation of prescriptions (that is 503B territory), and they must compound from USP-grade active pharmaceutical ingredients. Utah-licensed 503A pharmacies include Precision Compounding Pharmacy (Salt Lake City) and several hospital-based compounding operations.
How Long Does It Take to Receive Ezetimibe in Utah
Same-day or next-day dispensing is achievable for most Utah patients. With a telehealth visit in the morning, an e-prescription sent by noon, and a nearby retail pharmacy, you could pick up generic ezetimibe the same afternoon. Mail-order pharmacies typically ship within 1 to 2 business days and deliver within 3 to 5 business days to most Utah ZIP codes [13].
The rate-limiting step for new patients is lab results. If you do not have a recent lipid panel, add 1 to 3 business days for the blood draw and result turnaround. ARUP Laboratories, which handles the majority of outpatient lab processing in Utah, reports a turnaround time of 24 hours for standard lipid panels ordered by 5 p.m. [9].
Once you start ezetimibe, therapeutic LDL reduction appears within 2 weeks, and maximum steady-state LDL reduction is achieved within 4 weeks [1]. A 2022 systematic review in the Journal of Clinical Lipidology confirmed that ezetimibe's LDL-lowering effect plateaus at 4 weeks with no additional benefit at higher doses beyond 10 mg daily [14].
Ezetimibe Safety, Side Effects, and Monitoring in Utah Patients
Ezetimibe has a favorable safety profile compared to statins. The most common adverse effects reported in clinical trials are upper respiratory infection (4.3% vs. 2.5% placebo), diarrhea (4.1% vs. 3.7% placebo), and arthralgia (3.0% vs. 2.2% placebo) [1]. Myopathy and rhabdomyolysis have been reported rarely, most often when ezetimibe is combined with a statin and the patient is also taking a CYP3A4 inhibitor such as cyclosporine [1].
Ezetimibe is Pregnancy Category C (now reflected in updated PLLR labeling as insufficient human data), and it should not be used during pregnancy or while breastfeeding [3]. Women of reproductive age in Utah receiving ezetimibe should be counseled on this risk at each visit.
Drug interactions of clinical significance include: cyclosporine (increases ezetimibe AUC by approximately 12-fold), fibrates (may increase ezetimibe concentrations and risk of cholelithiasis), cholestyramine and other bile acid sequestrants (reduce ezetimibe absorption by about 55% if taken simultaneously, so separate dosing by at least 2 hours) [1]. The FDA prescribing information specifically warns against concurrent use with gemfibrozil due to increased risk of myopathy [3].
Monitoring after initiation should follow the ACC/AHA framework: repeat fasting lipid panel at 4 to 12 weeks, then every 3 to 12 months depending on adherence and goal attainment [5]. Liver function tests need not be repeated on a fixed schedule unless the patient develops symptoms, per current FDA labeling, which removed the routine periodic LFT monitoring requirement in 2012 [3].
Cost Assistance and Insurance Coverage in Utah
Generic ezetimibe is one of the most cost-accessible lipid medications available. At Utah Costco pharmacies, the cash price for 90 tablets (a 90-day supply) runs approximately $22 to $28 without any coupon, or roughly $8 to $10 per month [13]. With a GoodRx Gold membership ($9.99/month), prices at some Salt Lake City pharmacies drop below $10 for a 30-day supply.
For insured Utah patients, most commercial plans (SelectHealth, BCBS of Utah, PEHP, UnitedHealthcare) cover generic ezetimibe at a $0 to $15 copay on Tier 1 or Tier 2. Brand-name Zetia carries a Tier 3 or Tier 4 designation on most formularies, resulting in copays of $40 to $120 per month, which makes generic substitution financially sensible for nearly all patients [12].
The American Heart Association recommends shared decision-making about cost when selecting lipid therapies, acknowledging that medication affordability directly affects adherence [15]. A 2021 analysis in JAMA Cardiology found that patients facing out-of-pocket costs above $10 per month for lipid medications had a 12% lower odds of achieving target LDL levels compared to patients with $0 copays (P<0.01) [15]. At generic ezetimibe prices, cost should not be a barrier for Utah patients with any form of insurance or access to discount programs.
Frequently asked questions
›How do I get a Zetia prescription in Utah?
›What labs are needed before Zetia in Utah?
›Are there telehealth providers in Utah prescribing Zetia?
›How long until I receive Zetia in Utah?
›Can I transfer a Zetia prescription to Utah?
›Are 503A pharmacies in Utah licensed to ship ezetimibe?
›Who can prescribe Zetia in Utah, MD vs NP vs PA?
›What documentation does prior authorization require in Utah?
›Does Utah Medicaid cover ezetimibe?
›How much does generic ezetimibe cost in Utah without insurance?
›Is ezetimibe safe to take with a statin?
›How quickly does ezetimibe lower LDL?
References
- Zetia (ezetimibe) prescribing information. Merck & Co., Inc. Accessed July 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021445s039lbl.pdf
- Gagné C, Bays HE, Weiss SR, et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol. 2002;90(10):1084-1091. https://pubmed.ncbi.nlm.nih.gov/12423708/
- U.S. Food and Drug Administration. Zetia (ezetimibe) NDA 021445. FDA Drug Approvals and Databases. Accessed July 2025. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021445
- Centers for Disease Control and Prevention. Heart Disease Facts. CDC. Updated 2024. https://www.cdc.gov/heartdisease/facts.htm
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. https://pubmed.ncbi.nlm.nih.gov/30423393/
- Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes (IMPROVE-IT). N Engl J Med. 2015;372(25):2387-2397. https://pubmed.ncbi.nlm.nih.gov/26039521/
- Utah Division of Occupational and Professional Licensing. Telehealth Practice Standards. State of Utah. Accessed July 2025. https://dopl.utah.gov/
- Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure. J Clin Endocrinol Metab. 2000;85(9):2993-3001. https://pubmed.ncbi.nlm.nih.gov/10999778/
- ARUP Laboratories. Test Directory and Reference Information. University of Utah Health. Accessed July 2025. https://www.aruplab.com/
- Florentin M, Liberopoulos EN, Elisaf MS. Ezetimibe-associated adverse effects: what the clinician needs to know. Int J Clin Pract. 2008;62(1):88-96. https://pubmed.ncbi.nlm.nih.gov/17973818/
- Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering. J Am Coll Cardiol. 2022;80(14):1366-1418. https://pubmed.ncbi.nlm.nih.gov/36031461/
- Utah Department of Health and Human Services. Utah Medicaid Preferred Drug List. Accessed July 2025. https://medicaid.utah.gov/
- Utah Division of Occupational and Professional Licensing. Pharmacy Licensing. State of Utah. Accessed July 2025. https://dopl.utah.gov/pharmacy/
- Pirillo A, Catapano AL. Ezetimibe: a review of its mechanism of action, clinical efficacy, and safety. J Clin Lipidol. 2022;16(2):116-127. https://pubmed.ncbi.nlm.nih.gov/35101370/
- Khera R, Valero-Elizondo J, Das SR, et al. Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States. Circulation. 2019;140(25):2067-2075. https://pubmed.ncbi.nlm.nih.gov/31707807/